Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
917K
-
Shares change
-
-8.21K
-
Total reported value, excl. options
-
$46.5M
-
Value change
-
-$416K
-
Number of buys
-
3
-
Number of sells
-
-9
-
Price
-
$50.66
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q2 2018
12 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q2 2018.
NOVOZYMES A S DKK 2.0 - COM has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 917K shares
.
Largest 10 shareholders include SOMERVILLE KURT F (213K shares), Hemenway Trust Co LLC (192K shares), Kidder Stephen W (114K shares), Broderick Brian C (108K shares), PUZO MICHAEL J (104K shares), Page Arthur B (42.7K shares), Delaney Dennis R (36.2K shares), Notis-McConarty Edward (30.7K shares), Dempze Nancy E (29K shares), and Fayerweather Charles (24.8K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.